Core Viewpoint - The company is nearing the completion of the Phase II clinical trial for the XTMAB project, with further announcements expected soon [1] Summary by Categories - **Clinical Trial Progress** - The Phase II clinical trial for the XTMAB project is approaching its conclusion [1]

Core Viewpoint - The company Jianyou Co., Ltd. (603707.SH) has announced that the Phase II clinical trial of the XTMAB project has concluded successfully, with plans to initiate Phase III clinical trials in the first quarter of next year [1] Group 1 - The Phase II clinical trial results for the XTMAB project are reported to be positive [1] - The anticipated start date for the Phase III clinical trial is projected for the first quarter of next year [1]